Clinical evidence show that senolytic compounds can double the efficacy of established actives - such as collagen-boosting peptides - by amplifying their impact on the main visible signs of ageing. By removing the biological roadblocks that limit conventional actives’ effectiveness, senolytic-enhanced formulations represent the future of evidence-based skin care, as DSM-Firmenich explains
The beauty industry is undergoing a fundamental transformation. Driven by holistic approaches to skin health and longevity, it is moving away from the traditional, unwinnable anti-ageing narratives to a science-driven approach that is focused on understanding the root causes of the signs of ageing and tackling them early enough to slow or prevent these processes.
This change in perspective is driven by increased life expectancy, health-conscious consumers across all demographics and results from pharma-inspired scientific studies.
Skin longevity plays an important part in the perception of age. A recent multiethnic study involving women from diverse backgrounds aged 50—65 years, demonstrated that maintaining a healthy skin appearance - defined by smooth texture, even tone, and minimal wrinkles - can extend the perception of youth.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
